Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125009753 | 12500975 | 3 | F | 2016 | 20160803 | 20160627 | 20160809 | EXP | US-SA-2016SA114989 | AVENTIS | 68.00 | YR | E | F | Y | 110.23000 | KG | 20160809 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125009753 | 12500975 | 1 | PS | PRALUENT | ALIROCUMAB | 1 | Unknown | Y | UNK | 125559 | 75 | MG | INJECTION | QOW | |||||
| 125009753 | 12500975 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | U | UNK | 0 | 20 | MG | QD | ||||||
| 125009753 | 12500975 | 3 | C | ALIROCUMAB PREFILLED PEN | ALIROCUMAB | 1 | 0 | ||||||||||||
| 125009753 | 12500975 | 4 | C | ZETIA | EZETIMIBE | 1 | 0 | 10 | MG | QD | |||||||||
| 125009753 | 12500975 | 5 | C | PREVACID | LANSOPRAZOLE | 1 | 0 | 30 | MG | QD | |||||||||
| 125009753 | 12500975 | 6 | C | METOPROLOL. | METOPROLOL | 1 | 0 | 25 | MG | BID | |||||||||
| 125009753 | 12500975 | 7 | C | CLARINEX | DESLORATADINE | 1 | 0 | 5 | MG | QD | |||||||||
| 125009753 | 12500975 | 8 | C | PATANASE | OLOPATADINE HYDROCHLORIDE | 1 | 0 | 2 | DF | QD | |||||||||
| 125009753 | 12500975 | 9 | C | NASACORT | TRIAMCINOLONE ACETONIDE | 1 | 2 PUFFS EACH NOSTRIL | 0 | |||||||||||
| 125009753 | 12500975 | 10 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 125009753 | 12500975 | 11 | C | MONTELUKAST SODIUM. | MONTELUKAST SODIUM | 1 | 0 | 10 | MG | TABLET | QD | ||||||||
| 125009753 | 12500975 | 12 | C | PROLIA | DENOSUMAB | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125009753 | 12500975 | 1 | Blood cholesterol increased |
| 125009753 | 12500975 | 4 | Blood cholesterol |
| 125009753 | 12500975 | 5 | Hyperchlorhydria |
| 125009753 | 12500975 | 6 | Blood pressure measurement |
| 125009753 | 12500975 | 7 | Sinus disorder |
| 125009753 | 12500975 | 8 | Sinus disorder |
| 125009753 | 12500975 | 9 | Sinus disorder |
| 125009753 | 12500975 | 12 | Bone density decreased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125009753 | 12500975 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125009753 | 12500975 | Asthenia | |
| 125009753 | 12500975 | Chills | |
| 125009753 | 12500975 | Constipation | |
| 125009753 | 12500975 | Diarrhoea | |
| 125009753 | 12500975 | Dizziness | |
| 125009753 | 12500975 | Faeces discoloured | |
| 125009753 | 12500975 | Fatigue | |
| 125009753 | 12500975 | Gait disturbance | |
| 125009753 | 12500975 | Headache | |
| 125009753 | 12500975 | Impaired driving ability | |
| 125009753 | 12500975 | Malaise | |
| 125009753 | 12500975 | Mobility decreased | |
| 125009753 | 12500975 | Pain | |
| 125009753 | 12500975 | Sinus congestion | |
| 125009753 | 12500975 | Tinnitus | |
| 125009753 | 12500975 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125009753 | 12500975 | 1 | 20160609 | 0 | ||
| 125009753 | 12500975 | 2 | 20160608 | 0 | ||
| 125009753 | 12500975 | 3 | 20160609 | 0 |